RAM
FURX

Redmond Asset Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Redmond Asset Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-9,759
Closed -$410K – 154
2013
Q4 		$410K Buy
9,759
+270
+3% +$11.1K 0.22% 113
2013
Q3 		$417K Buy
+9,489
New +$393K 0.24% 99

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Redmond Asset Management's FURX Position: Q1 2014 in Review

Redmond Asset Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q1 2014, closing a stake of 9,759 shares — an estimated $410K sold.

Redmond Asset Management first reported a position in FURX in Q3 2013 and held it in 2 quarters. The position peaked at $417K in Q3 2013. 114 funds tracked by Wall St. Rank hold FURX as of Q1 2014.

  • Redmond Asset Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
  • Redmond Asset Management sold 9,759 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q1 2014, an estimated $410K.
  • Redmond Asset Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 2 quarters.
  • Redmond Asset Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $417K in Q3 2013.
  • 114 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q1 2014.

Based on Redmond Asset Management's 13F filing for Q1 2014, filed 14 May 2014.